Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZJU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,185
Award facts
- Contract value 100% obligated
- $29,185.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,185.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule in unit dose packaging (30-count). The contract, which carries no set-aside designation, was competitively awarded on December 19, 2025, with an ultimate completion date of January 13, 2026. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables comprehensive pharmaceutical support for military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor supplying medications, vaccines, and medical supplies across therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Vyndamax (tafamidis) is a transthyretin stabilizer used to treat cardiac amyloidosis, reflecting the company's role in delivering specialized pharmaceuticals for military medical readiness. The delivery order exemplifies AmerisourceBergen's consistent participation in DLA's pharmaceutical procurement pipeline through competitively awarded transactions with firm fixed pricing.
Quick answers
Who was awarded contract SPE2DR26F4ZJU?
SPE2DR26F4ZJU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26F4ZJU worth?
The government has obligated $29,185 on SPE2DR26F4ZJU.
Is contract SPE2DR26F4ZJU an order under another contract?
Yes. SPE2DR26F4ZJU is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZJU competed?
The extent of competition for SPE2DR26F4ZJU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award